Edwards Lifesciences Corp
EWNYSECIK 1099800HealthcareFiscal year ends Dec 31
Reports and events: 238 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-2820:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001099800-26-000048 |
| 2026-08-0420:14 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001099800-26-000043 |
| 2026-07-2320:29 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-26-000038 |
| 2026-05-0820:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001099800-26-000028 |
| 2026-05-0620:12 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001099800-26-000026 |
| 2026-05-0420:53 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001099800-26-000023 |
| 2026-04-2320:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-26-000021 |
| 2026-03-2620:05 ET | DEF 14A | Proxy statementPeriod 2026-05-07 | 0001099800-26-000015 |
| 2026-02-2521:11 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001099800-26-000009 |
| 2026-02-1021:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-26-000006 |
| 2026-01-1223:51 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001099800-26-000002 |
| 2025-11-0521:12 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001099800-25-000062 |
| 2025-10-3020:29 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-258662 |
| 2025-10-3020:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-25-000059 |
| 2025-08-1920:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001099800-25-000056 |
| 2025-08-0620:04 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001099800-25-000048 |
| 2025-08-0617:43 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001099800-25-000046 |
| 2025-07-2522:22 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-164527 |
| 2025-07-2420:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-25-000037 |
| 2025-05-0821:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001099800-25-000026 |
| 2025-05-0620:13 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001099800-25-000023 |
| 2025-04-2320:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-25-000020 |
| 2025-03-2620:16 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001099800-25-000013 |
| 2025-02-2821:50 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001099800-25-000005 |
| 2025-02-1121:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-25-000003 |
| 2024-11-0621:20 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001099800-24-000086 |
| 2024-10-2420:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-24-000084 |
| 2024-09-0320:34 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001099800-24-000082 |
| 2024-07-3120:14 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001099800-24-000078 |
| 2024-07-2420:26 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events | 0001099800-24-000069 |
| 2024-07-1513:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001099800-24-000066 |
| 2024-07-1020:39 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001099800-24-000061 |
| 2024-06-1721:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001099800-24-000054 |
| 2024-06-0310:38 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-152323 |
| 2024-05-0820:52 ET | 8-K | 5.07 Shareholder vote results | 0001099800-24-000045 |
| 2024-04-2920:06 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001099800-24-000039 |
| 2024-04-2520:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-24-000037 |
| 2024-03-2620:07 ET | DEF 14A | Proxy statementPeriod 2023-12-31 | 0001099800-24-000032 |
| 2024-03-2620:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001099800-24-000031 |
| 2024-02-1221:47 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001099800-24-000004 |
| 2024-02-0621:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-24-000002 |
| 2023-12-0713:37 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001099800-23-000042 |
| 2023-10-2720:49 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001099800-23-000039 |
| 2023-10-2520:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-23-000037 |
| 2023-07-2820:32 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001099800-23-000034 |
| 2023-07-2620:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-23-000032 |
| 2023-05-1516:50 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-23-144564 |
| 2023-04-2820:49 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001099800-23-000021 |
| 2023-04-2620:29 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-23-000019 |
| 2023-03-2820:16 ET | DEF 14A | Proxy statement | 0001099800-23-000013 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.